NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 845 filers reported holding NOVARTIS A G in Q2 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $217,000 | -7.7% | 2,360 | -1.3% | 0.01% | 0.0% |
| Q2 2015 | $235,000 | +5.4% | 2,390 | +5.9% | 0.01% | +7.7% |
| Q1 2015 | $223,000 | +10.4% | 2,257 | +3.6% | 0.01% | 0.0% |
| Q4 2014 | $202,000 | -2.4% | 2,179 | -0.8% | 0.01% | -13.3% |
| Q3 2014 | $207,000 | -4.2% | 2,197 | -8.0% | 0.02% | -6.2% |
| Q2 2014 | $216,000 | -1.8% | 2,388 | -7.6% | 0.02% | -5.9% |
| Q1 2014 | $220,000 | +1.9% | 2,584 | -3.7% | 0.02% | -5.6% |
| Q4 2013 | $216,000 | +4.9% | 2,684 | 0.0% | 0.02% | -10.0% |
| Q3 2013 | $206,000 | -3.7% | 2,684 | -11.3% | 0.02% | -9.1% |
| Q2 2013 | $214,000 | -8.9% | 3,025 | -8.4% | 0.02% | -15.4% |
| Q1 2013 | $235,000 | -27.2% | 3,303 | -43.9% | 0.03% | -39.5% |
| Q2 2012 | $323,000 | -11.3% | 5,889 | -10.8% | 0.04% | -2.3% |
| Q1 2012 | $364,000 | +6.1% | 6,604 | +9.4% | 0.04% | -4.3% |
| Q4 2011 | $343,000 | -20.4% | 6,038 | -20.8% | 0.05% | -27.0% |
| Q3 2011 | $431,000 | – | 7,619 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |